Metformin Lowers Risk for Pancreatic Cancer
Metformin, one of the most widely used diabetes drugs, may offer patients the added benefit of lowering their odds for pancreatic cancer by 62%, a new study shows. But the study had a downside: other common treatments, including the use of insulin or insulin-releasing medications such as sulfonylureas, seemed to
Continua a leggere